A double blind, randomized, placebo controlled trial of aripiprazole plus valproate [valproic acid] in the short-term and long-term treatment of bipolar disorder.

Trial Profile

A double blind, randomized, placebo controlled trial of aripiprazole plus valproate [valproic acid] in the short-term and long-term treatment of bipolar disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2012

At a glance

  • Drugs Aripiprazole (Primary) ; Valproic acid
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Acronyms ABLE
  • Sponsors Korea Otsuka Pharmaceutical
  • Most Recent Events

    • 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov.
    • 22 Dec 2009 Planned end date changed from 1 Sep 2008 to 1 Jun 2009 as reported by ClinicalTrials.gov.
    • 22 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top